pharma · Minimal Residual Disease · Pancreatic Ductal Adenocarcinoma · ELTX
Elicio Therapeutics
News and analysis for Elicio Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Boston, USA HQ
47 Employees
Public company Type
ELTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 47
- Programs
- 2
- Drugs
- 0
- Patents
- 4
News & analysis
NovaPharmaNews articles mentioning Elicio Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Elicio Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.